Research remains the catalyst for future breakthroughs. Supporting investigators within every rheumatology research discipline to be able to learn, conduct, fund and disseminate their research exemplifies the ACR mission to empower rheumatology professionals to excel in their specialty and advance discoveries that will benefit patients with rheumatic disease. I look forward to seeing what new innovations await us at ACR Convergence 2025.
Carol A. Langford, MD, MHS, is the director of the Center for Vasculitis Care and Research in the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic, where she is professor of medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, and holds the Harold C. Schott endowed chair in rheumatic and immunologic diseases.